drugset
Drugs / neoantigen-activated T-cell therapy
last change Mar 2023 re-read 3 minutes ago

neoantigen-activated T-cell therapy

Cell therapy

Developed for
hepatocellular carcinoma
Investigated by
Sixth Affiliated Hospital, Sun Yat-sen University · Sun Yat-sen University · The First Affiliated Hospital of Guangzhou Medical University

Trials 1

today NCT03067493 · Ph 2
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03067493 Jul 2017 → Mar 2023 hepatocellular carcinoma Sun Yat-sen University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as neoantigen-activated T-cell therapy “We designed a personalized neoantigen-loaded dendritic cell vaccine and neoantigen-activated T-cell therapy” PMID 35476700 ↗ Jun 2022
Modality Cell therapy “neoantigen-activated T-cell therapy” PMID 35476700 ↗ Jun 2022